FY2025 EPS Estimate for Spectral AI Decreased by Analyst

Spectral AI, Inc. (NASDAQ:MDAI) – Equities research analysts at Northland Capmk decreased their FY2025 EPS estimates for Spectral AI in a research note issued on Wednesday, August 13th. Northland Capmk analyst C. Byrnes now anticipates that the company will post earnings of ($0.35) per share for the year, down from their previous forecast of ($0.15). The consensus estimate for Spectral AI’s current full-year earnings is ($0.48) per share.

Spectral AI (NASDAQ:MDAI) last issued its quarterly earnings results on Tuesday, August 12th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.03). The business had revenue of $5.07 million for the quarter, compared to analyst estimates of $5.44 million.

Separately, Wall Street Zen downgraded shares of Spectral AI from a “hold” rating to a “strong sell” rating in a report on Saturday.

Spectral AI Price Performance

Shares of NASDAQ:MDAI opened at $2.11 on Monday. Spectral AI has a 1-year low of $0.82 and a 1-year high of $3.25. The company has a market capitalization of $53.43 million, a P/E ratio of -3.06 and a beta of 0.90. The firm’s 50 day simple moving average is $2.42 and its two-hundred day simple moving average is $1.83.

Hedge Funds Weigh In On Spectral AI

Several hedge funds have recently modified their holdings of the stock. Jane Street Group LLC purchased a new position in shares of Spectral AI in the second quarter worth $74,000. Marshall Wace LLP purchased a new position in shares of Spectral AI in the second quarter worth $104,000. XTX Topco Ltd purchased a new position in shares of Spectral AI in the second quarter worth $123,000. DNB Asset Management AS purchased a new position in shares of Spectral AI in the second quarter worth $107,000. Finally, Geode Capital Management LLC lifted its holdings in shares of Spectral AI by 21.8% in the second quarter. Geode Capital Management LLC now owns 152,958 shares of the company’s stock worth $379,000 after buying an additional 27,365 shares in the last quarter. Hedge funds and other institutional investors own 67.08% of the company’s stock.

About Spectral AI

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.